NDC 68180-314 – Imipramine Pamoate
Imipramine Pamoate 75 mg/1 · Capsule · Oral
Product NDC68180-314
Product details
- Brand name
- Imipramine Pamoate
- Generic name
- Imipramine Pamoate
- Labeler
- Lupin Pharmaceuticals, Inc.
- Dosage form
- Capsule
- Route
- Oral
- Marketing category
- ANDA · ANDA090444
- Marketed since
- April 16, 2010
- Listing expires
- December 31, 2027
- Pharmacologic class
- Tricyclic Antidepressant
Active ingredients
- Imipramine Pamoate 75 mg/1
Uses, dosage, side effects and warnings for Imipramine Pamoate →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 68180-314-06 | 30 CAPSULE in 1 BOTTLE (68180-314-06) | Apr 16, 2010 |
Recalls mentioning this NDC
- D-0027-2022 Oct 27, 2021 · Class II
Out of specification result observed in a dissolution test at the 9-month long term stability time point.
Other Imipramine Pamoate products
- 0054-0273 Imipramine Pamoate 75 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc
- 0054-0274 Imipramine Pamoate 100 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc
- 0054-0275 Imipramine Pamoate 125 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc
- 0054-0276 Imipramine Pamoate 150 mg/1 · Capsule · Hikma Pharmaceuticals USA Inc
- 68180-315 Imipramine Pamoate 100 mg/1 · Capsule · Lupin Pharmaceuticals, Inc.
- 68180-316 Imipramine Pamoate 125 mg/1 · Capsule · Lupin Pharmaceuticals, Inc.
- 68180-317 Imipramine Pamoate 150 mg/1 · Capsule · Lupin Pharmaceuticals, Inc.
- 70518-4730 Imipramine Pamoate 75 mg/1 · Capsule · REMEDYREPACK INC.